TRV GP III, LLC
- SEC CIK
- 0001637299
- Latest filing
- Feb 14, 2024
Holdings in Q1 2022
Holdings as of Mar 31, 2022, filed May 10, 2022. Long positions only; changes compare share counts with Q4 2021.
- Positions
- 7
- 0 vs. Q4 2021
- Portfolio value
- $368.5M
- −$31.1M (−7.8%) vs. Q4 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| RVMDRevolution Medicines, Inc. | COM | 5,524,031 | $140.9M | 38.2% | 00.0% | Unchanged | History |
| FULCFulcrum Therapeutics, Inc. | COM | 3,962,202 | $93.7M | 25.4% | 00.0% | Unchanged | History |
| VYGRVoyager Therapeutics, Inc. | COM | 6,391,176 | $48.7M | 13.2% | 00.0% | Unchanged | History |
| PLRXPliant Therapeutics, Inc. | COM | 5,839,160 | $40.9M | 11.1% | 00.0% | Unchanged | History |
| NRIXNurix Therapeutics, Inc. | COM | 1,922,549 | $26.9M | 7.3% | −500,000−20.6% | Reduced | History |
| DBTXDecibel Therapeutics, Inc. | COM | 3,139,685 | $9.54M | 2.6% | 00.0% | Unchanged | History |
| JNCEJounce Therapeutics, Inc. | COM | 1,148,780 | $7.80M | 2.1% | 00.0% | Unchanged | History |